Vimarsana
Biggest News Aggregation in the World

Page 13 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on September 29,...

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STAMFORD, Conn., Sept. 22, 2023 -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that, effective as of October 1, the compensation...

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen, Inc., , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that on September 18, 2023, and in connection with the previously...

Sonder Holdings Inc. Reports Inducement Grants Under Nasdaq - Vimarsana News

Sonder Holdings Inc. Reports Inducement Grants Under Nasdaq

THORNTON, Colo., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sonder Holdings Inc. (NASDAQ: SOND; “Sonder”) today announced that on September 12, 2023, the...

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - Vimarsana News

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and